Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPulmonologyallcareadvantage non-preferred inhaler Coverage | …
    Ask Trek AI about this page
    CurrentallcareadvantagePolicy 017.2

    Approval criteria for Non-preferred inhalers and/or regimens

    Customize your policy alerts

    Sign up for allcareadvantage Policy 017.2 alerts

    Get alerted when Policy 017.2 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines prior authorization and approval criteria for coverage of non-preferred inhaler products and inhaler regimens for members with asthma, reactive airways disease (RAD), or COPD who are established on a reliever (e.g., albuterol). Applies to AllCare Advantage members.

    Policy Summary
    Payerallcareadvantage
    PolicyApproval criteria for Non-preferred inhalers and/or regimens
    Policy CodePolicy 017.2
    Change TypeNo material change
    Effective DateJun 2, 2026
    Last ReviewJun 1, 2028
    Next Review DateJun 1, 2028
    Key ActionObtain prior authorization and document diagnosis, reliever medication, and trial of preferred formulary inhaler(s) with good compliance before requesting non-preferred inhalers.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Up to 1 YearApproval length
    1 inhaler/monthQuantity limit
    Asthma, RAD, COPDCovered indications
    Class SpecificClassification

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria for Non-Preferred Inhalers and Regimens

    There are no additional explicit exclusions beyond failure to meet the policy’s sequential approval criteria. Requests will be denied when required steps in the decision flow are not met, including lack of documentation of the qualifying diagnosis (asthma, reactive airways disease, or COPD) or lack of documentation of a reliever medication for acute symptoms (e.g., albuterol).

    The requested non-preferred drug and/or regimen must be FDA‑approved for the submitted and/or comorbid diagnoses or be supported by clinical guidelines or appropriate compendia to meet approval criteria. If the agent/regimen is not FDA‑approved for the indication and lacks guideline/compendia support, the request will be denied as not meeting criteria.

    Coding and Quantity Limits

    No specific codes listedmixed
    No codes listed
    Quantity limit
    Quantity limit1 inhaler per month

    Provider Actions, Documentation, and Denial Triggers

    Prior Authorization

    Prior authorization required for non-preferred inhalers/regimens

    Prior authorization is required for requests for non-preferred inhaler products or inhaler regimens; coverage decisions follow the policy’s stepwise review of diagnosis, reliever availability, preferred status, trials of preferred agents with good compliance, consideration of preferred combination alternatives, and FDA approval or supporting guideline/compendia evidence.

    Step Therapy

    Step therapy: trial of preferred formulary inhaler(s) required

    Members must trial preferred formulary inhaler(s) or regimen(s) and demonstrate good compliance before approval of non-preferred agents; prescribers should consider switching to a preferred combination inhaler when available to reduce inhaler burden and cost.

    Documentation Required

    Required documentation: diagnosis and reliever medication

    Provide documentation that supports the diagnosis of asthma, reactive airways disease (RAD), or COPD and documentation that the member has a reliever medication for acute symptoms (e.g., albuterol).

    • Clinical record or diagnostic documentation confirming asthma, RAD, or COPD
    • Medication list or prescription showing a reliever (e.g., albuterol) on the current regimen
    Documentation Required

    Document trials and compliance when preferred options were used

    If the request is for a non-preferred product, document a trial of preferred formulary inhaler(s)/regimen(s) with good compliance and note consideration of preferred combination inhalers as alternatives; if preferred options were tried and denied by the prescriber, document the clinical reason.

    • Dates and duration of trial(s) of preferred inhaler(s)/regimen(s)
    • Evidence of good adherence during the trial(s)
    • If prescriber declines a suggested preferred combination, a statement of clinical rationale for not switching
    Denial Risk

    Denial triggers: missing diagnosis, no reliever, or lacking FDA/guideline support

    Requests may be denied if there is no documentation of the required diagnosis (asthma, RAD, or COPD) or if there is no documentation that the member has a reliever medication for acute symptoms (e.g., albuterol); requests for drugs/regimens that are not FDA‑approved for the submitted/comorbid diagnoses and not supported by guidelines/compendia will also be denied.

    • Missing or absent diagnostic documentation → deny
    • No evidence of reliever medication on the member’s regimen → deny
    • Requested drug/regimen not FDA‑approved for the diagnosis and not supported by clinical guidelines/appropriate compendia → deny

    Definitions and Examples

    Reliever medication
    DefinitionAn as-needed short-acting bronchodilator for acute symptoms (example: albuterol).
    Use caseMember must be established on a reliever medication when requesting non-preferred inhaler/regimen.
    Clinical roleReliever provides acute symptom relief separate from maintenance inhaler therapy.
    Agents included
    Examples of agentsTrelegy Ellipta; Breztri; Flovent HFA 220 mcg; single-drug inhalers used in combination.
    ScopeIncludes combination products and single-agent inhalers when used together to manage disease.
    Policy coverage note

    Background

    Chronic airflow limitation conditions such as asthma and COPD are commonly managed with inhaled maintenance therapies plus an as‑needed reliever medication for acute symptoms (example: albuterol). Treatment complexity and the number of separate inhalers can reduce adherence; where possible, preferred combination inhalers may improve adherence, reduce inhaler burden, and lower cost. AllCare Advantage requires documentation of diagnosis and reliever availability and prefers trials of formulary preferred inhalers with good compliance prior to approving non-preferred inhalers or regimens.

    Policy Summary
    Payerallcareadvantage
    PolicyApproval criteria for Non-preferred inhalers and/or regimens
    Policy CodePolicy 017.2
    Change TypeNo material change
    Effective DateJun 2, 2026
    Last ReviewJun 1, 2028
    Next Review DateJun 1, 2028
    Key ActionObtain prior authorization and document diagnosis, reliever medication, and trial of preferred formulary inhaler(s) with good compliance before requesting non-preferred inhalers.
    SourceLink
    On This Page
    Coverage Criteria for Non-Preferred Inhalers and RegimensCoding and Quantity LimitsProvider Actions, Documentation, and Denial TriggersDefinitions and ExamplesBackground
    Non-preferred agents are covered when members have failed preferred agents or regimens and meet approval criteria.